| Molecular mechanisms of metastasis in breast cancer—clinical applications M Mego, SA Mani, M Cristofanilli Nature reviews Clinical oncology 7 (12), 693-701, 2010 | 306 | 2010 |
| Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment M Giuliano, A Giordano, S Jackson, KR Hess, U De Giorgi, M Mego, ... Breast Cancer Research 13, 1-9, 2011 | 253 | 2011 |
| Epithelial–mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer A Giordano, H Gao, S Anfossi, E Cohen, M Mego, BN Lee, S Tin, ... Molecular cancer therapeutics 11 (11), 2526-2534, 2012 | 240 | 2012 |
| Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study M Mego, J Chovanec, I Vochyanova-Andrezalova, P Konkolovsky, ... Complementary therapies in medicine 23 (3), 356-362, 2015 | 206 | 2015 |
| Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy M Mego, SA Mani, BN Lee, C Li, KW Evans, EN Cohen, H Gao, ... International journal of cancer 130 (4), 808-816, 2012 | 185 | 2012 |
| Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination M Giuliano, A Giordano, S Jackson, U De Giorgi, M Mego, EN Cohen, ... Breast cancer research 16, 1-9, 2014 | 150 | 2014 |
| Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors Z Cierna, M Mego, V Miskovska, K Machalekova, M Chovanec, ... Annals of oncology 27 (2), 300-305, 2016 | 145 | 2016 |
| Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer Z Cierna, M Mego, P Janega, M Karaba, G Minarik, J Benca, ... BMC cancer 14, 1-8, 2014 | 137 | 2014 |
| Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells M Mego, U De Giorgi, S Dawood, X Wang, V Valero, E Andreopoulou, ... International journal of cancer 129 (2), 417-423, 2011 | 131 | 2011 |
| Inflammation mediated metastasis: immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells EN Cohen, H Gao, S Anfossi, M Mego, NG Reddy, B Debeb, A Giordano, ... PloS one 10 (7), e0132710, 2015 | 122 | 2015 |
| Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+ CD24lo cancer stem … JM Reuben, BN Lee, H Gao, EN Cohen, M Mego, A Giordano, X Wang, ... European journal of cancer 47 (10), 1527-1536, 2011 | 122 | 2011 |
| Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy M Mego, V Holec, L Drgona, K Hainova, S Ciernikova, V Zajac Complementary therapies in medicine 21 (6), 712-723, 2013 | 111 | 2013 |
| Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer U De Giorgi, M Mego, E Scarpi, M Giuliano, A Giordano, JM Reuben, ... Clinical breast cancer 12 (4), 264-269, 2012 | 111 | 2012 |
| Circulating tumor cells and bone metastases as detected by FDG–PET/CT in patients with metastatic breast cancer U De Giorgi, V Valero, E Rohren, M Mego, GV Doyle, MC Miller, NT Ueno, ... Annals of oncology 21 (1), 33-39, 2010 | 101 | 2010 |
| Circulating tumor cells (CTC) are associated with defects in adaptive immunity in patients with inflammatory breast cancer M Mego, H Gao, EN Cohen, S Anfossi, A Giordano, T Sanda, TM Fouad, ... Journal of Cancer 7 (9), 1095, 2016 | 88 | 2016 |
| Prognostic value of EMT-circulating tumor cells in metastatic breast cancer patients undergoing high-dose chemotherapy with autologous hematopoietic stem cell transplantation M Mego, H Gao, BN Lee, EN Cohen, S Tin, A Giordano, Q Wu, P Liu, ... Journal of Cancer 3, 369, 2012 | 84 | 2012 |
| Systemic immune-inflammation index in germ-cell tumours M Chovanec, Z Cierna, V Miskovska, K Machalekova, K Kalavska, ... British journal of cancer 118 (6), 831-838, 2018 | 83 | 2018 |
| 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer U De Giorgi, M Mego, EM Rohren, P Liu, BC Handy, JM Reuben, ... Journal of Nuclear Medicine 51 (8), 1213-1218, 2010 | 83 | 2010 |
| CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer M Mego, D Cholujova, G Minarik, T Sedlackova, P Gronesova, M Karaba, ... Bmc Cancer 16, 1-9, 2016 | 78 | 2016 |
| Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors M Chovanec, Z Cierna, V Miskovska, K Machalekova, D Svetlovska, ... Oncotarget 8 (13), 21794, 2017 | 70 | 2017 |
Francisco J. EstevaChief, Breast Medical Oncology, Northwell Health Cancer Institute at Lenox Hill HospitalVerified email at northwell.edu
